ESR1 and breast carcinoma: Since the protein product of ESR1, ERα, is the main driver of estrogen‐target gene transcriptional activation, ER+ breast cancer development, and endocrine drug resistance, we proposed that LINC02568 might regulate the expression of ESR1 to exert its functions in such aspects.